Characteristic | Data |
---|---|
Patients | 20 (100%) |
Sex | |
Female | 13 (65%) |
Male | 7 (35%) |
Age at 68Ga-DOTATATE PET (y) | |
Mean ± SD | 56 ± 12 |
Range | 28–78 |
NET primary tumor subtype (%) | |
Pancreatic | 11 (55%) |
Small intestine | 5 (25%) |
Other | 3 (15%) |
Unknown | 1 (5%) |
Gastroenteropancreatic NET grade | |
G1 (Ki-67 < 3%) | 5 (29%) |
G2 (Ki-67 = 3%–20%) | 9 (53%) |
G3 (Ki-67 > 20%) | 3 (18%) |
Local recurrence | 1 (5%) |
Metastases | |
No | 2 (10%) |
Yes | 18 (90%) |
Metastatic sites | |
Liver | 18 |
Nodes | 8 |
Bone | 3 |
Adrenal | 2 |
Mesenteric | 2 |
Cardiac | 1 |
Splenic | 1 |
Clinical syndrome | |
Nonfunctioning tumor | 12 (60%) |
Functioning tumor | 8 (40%) |
Data are number, except for age.